Podchaser Logo
Home
Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Released Monday, 23rd March 2015
Good episode? Give it some love!
Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Dr. Jerry Mendell Discusses Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy :: March 2015

Monday, 23rd March 2015
Good episode? Give it some love!
Rate Episode

Guest: Jerry Mendell, MD, is Director of the Center for Gene Therapy in The Research Institute, Director of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, and Curran-Peters Chair of Pediatric Research at Nationwide Children’s Hospital. He is also an attending neurologist at Nationwide Children’s and a professor of pediatrics and neurology at The Ohio State University College of Medicine.

• View the published abstract for this month’s featured research article.• Learn more about the gene therapy trial for Becker Muscular Dystrophy.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features